TERC and esophageal cancer: Although we observed no additional TERC mutations, our analysis identified a telomerase variant (A279T) that occurred nearly five-fold more frequently in esophageal cancer patients compared to healthy blood donors; the frequency of A279T variant expression in esophageal cancers exceeds that of recently described ALK mutations in non-small cell lung cancers [45].